Farmaceutici S.p.A. Fidia
CIK 1479105 · last filed 2013-08-08
Farmaceutici S.p.A. Fidia is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2013. The most recent filing shows the insider sold $93.4M of ANIK on Aug 8, 2013. Across all open-market trades the lifetime net is −$124.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $21.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$21.55M
1
2
-$124.56M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIK | 10%+ Owner | 1,422,384 | $15.15 | $21.55M | -$124.56M | 2 | 2013-08-08 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-08-08 | ANIK | Sell (S) | −3,810,000 | -$93.42M | EDGAR |
| 2013-08-08 | ANIK | Sell (S) | −1,270,000 | -$31.14M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.